Optometry in Practice (OiP), the College's quarterly CPD journal, covers the latest research, analysis and opinion from your profession, and provides up to 4 CPD points.
The work of the OLGA clinic at Manchester Royal Eye Hospital.
Introduction
Glaucoma is a major cause of visual impairment in the UK. The increased prevalence of glaucoma with age combined with demographic changes in the population means that the morbidity associated with this condition is rising, causing increasing demands on the Hospital Eye Service (HES). Once diagnosed with glaucoma, patients will remain under the care of the HES for the rest of their life. Furthermore, there is a considerable number of individuals, who are either at risk of developing or are suspected of having glaucoma, who also require long-term monitoring within this setting. It is estimated that the management of patients with glaucoma, or suspect glaucoma, currently accounts for approximately 25% of all follow-up attendances (Vernon et al. 2004), with this number likely to increase as the population ages, as case detection improves and as evidence for the early and effective treatment of glaucoma accumulates.
Sign in to continue
Sign in to view the article
Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Pressure on optometrists to treat glaucoma is likely to grow as case numbers are predicted to rise 44% by 2035. Beta blockers will remain a part of the fight ahead, as Adrian O’Dowd reports.